PCAT6 and hepatocellular carcinoma: Kaplan-Meier analysis indicated that patients with lower PCAT6 expression levels had significantly longer OS (P < 0.001) and disease-free survival (DFS) (P < 0.05), suggesting that PCAT6 overexpression is correlated with poor prognosis of HCC patients (31).